Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Clinical trial NCT05371353 · RECRUITING

Trial details

NCT number: NCT05371353
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

HPV Infections Cervical Cancer Stage IIa Vaginal Cancer Genital Wart CIN1 CIN2 CIN3

Start date: 2022-05-14
Primary completion: 2027-05-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.